Ght, BMI and CVD threat scores (CRFs and CRFs + fit) had been equivalent in both genders. When the Bonferroni correction aspect for several tests was applied, only those with P 0.0025 remained substantial.CorrelationsPartial correlations involving PA intensities and CVD risk scores (CRFs and CRFs + fit) in both age groups have been investigated following adjustment for country. In young young children, only vigorous PA was inversely correlated with all the CVD risk score CRFs (r: -0.086; P 0.01; n = 994). In older children, moderate PA, vigorous PA, MVPA and total PA intensities had been inversely correlated with both CVD danger scores (score CRFs ranged from -0.089 to -0.166, all P 0.01, n = two,025; score CRFs + fit ranged from -0.111 to -0.251, all P 0.001, n = 835).Differences in mean Z score by quintiles of PAVigorous PA intensity was the only PA variable that was related to CVD risk score in younger kids. InJim ez-Pav et al. BMC Medicine 2013, 11:172 http://www.biomedcentral/1741-7015/11/Page five ofTable 1 Descriptive qualities of your study participantsCharacteristic Group two to 6 years Age, years Physique mass, kg Height, cm BMI, kg/m2a Sum of two skinfolds, mm DBP, mmHg SBP, mmHg Glucose, mmol/l Insulin, pmol/la HOMA-IRa Cholesterol, mmol/l HDL-c, mmol/l Triglycerides, mmol/l Light PA, min/daya Moderate PA, min/day Vigorous PA, min/day MVPA, min/day Total PA, cpm CVD threat score CRFs Group 6 to 9 years Age, years Body mass, kg Height, cm BMI, kg/m2a Sum of two skinfolds, mma DBP, mmHg SBP, mmHg Glucose: mmol/l Insulin, pmol/la HOMA-IRa a a a aAll n = 994 four.4 0.8 18.3 three.five 107.two 7.4 15.8 1.7 16.5 five.0 62.1 6.two 97.4 8.4 4.51 0.51 22.64 18.47 0.68 0.62 4.02 0.73 1.23 0.34 0.46 0.25 395 65 31 16 5 36 20 598 174 0.02 two.74 n = 2,025 7.six 0.8 27.7 6.7 127.five 7.three 16.9 two.9 19.8 9.five 64.2 6.5 103.2 eight.7 4.81 0.52 35.84 24.65 1.13 0.83 4.19 0.83 1.40 0.38 0.47 0.26 364 64 35 17 8 43 22 581 169 41.7 14.5 1.9 1.Boys n = 524 four.five 0.eight 18.five 3.five 107.eight 7.4 15.9 1.6 15.three four.3 62.0 6.1 97.7 eight.five 4.55 0.54 21.39 17.36 0.65 0.57 3.99 0.72 1.29 0.33 0.45 0.23 400 65 34 17 6 39 21 627 179 0.01 2.70 n = 1,038 7.6 0.eight 28.0 six.9 128.two 7.four 16.9 3.0 18.three 9.2 64.0 six.7 103.7 8.7 4.88 0.52 33.41 22.43 1.07 0.77 4.11 0.77 1.42 0.39 0.45 0.24 364 63 41 19 8 49 23 609 175 42.2 14.three 2.1 1.Girls n = 470 4.four 0.8 18.0 three.four 106.6 7.5 15.7 1.8 17.7 5.3 62.2 6.3 97.1 8.two 4.46 0.48 24.10 19.52 0.72 0.66 four.06 0.74 1.19 0.35 0.48 0.28 390 66 27 14 5 32 17 565 162 0.03 two.77 n = 987 7.6 0.8 27.5 6.3 126.9 7.three 16.9 two.eight 21.4 9.two 64.five 6.3 102.8 eight.six four.75 0.49 38.34 24.93 1.20 0.84 4.28 0.84 1.38 0.37 0.49 0.29 364 17 30 12 7 37 18 553 157 41.three 13.8 1.7 1.P worth 0.226 0.011 0.011 0.170 0.001b 0.617 0.238 0.010 0.011 0.Lirentelimab 011 0.Netupitant 127 0.PMID:23460641 001b 0.188 0.019 0.001b 0.281 0.001b 0.001b 0.879 0.926 0.088 0.001b 0.618 0.070 0.018 0.070 0.001b 0.001b 0.001b 0.001b 0.016 0.001b 0.940 0.001b 0.001b 0.001b 0.001b 0.01 0.001bCholesterol, mmol/l HDL-c, mmol/l Triglycerides, mmol/l Light PA, min/daya Moderate PA, min/daya Vigorous PA, min/daya MVPA, min/daya Total PA, cpm Cardiorespiratory fitness, ml/kg/minc Stages (total quantity)Jim ez-Pav et al. BMC Medicine 2013, 11:172 http://www.biomedcentral/1741-7015/11/Page six ofTable 1 Descriptive characteristics from the study participants (Continued)CVD risk score CRFs CVD danger score CRFs + fitc 0.13 three.11 -0.28 three.26 0.09 three.03 -0.26 three.016 0.18 three.19 -0.31 3.36 0.501 0.CVD risk score CRFs consists of SBP, HOMA-IR, ratio cholesterol/HDL-c, triglycerides and sum of two skinfolds; CVD threat score CRFs +.